COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HEPATITIS B VIRUS
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Hepatitis B Virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Hepatitis B Virus infection using said pharmaceutical composition: and methods for inhibiting the expression of a Hepatitis B Virus gene in a cell..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 07. März Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
CHIN DANIEL [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-03-07, Last update posted on www.tib.eu: 2024-01-01, Last updated: 2024-01-05 |
---|
Patentnummer: |
CA3064103 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA016601246 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA016601246 | ||
003 | DE-627 | ||
005 | 20240105084529.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230607s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA016601246 | ||
035 | |a (EPA)CA3064103 | ||
035 | |a (EPA)47391267 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a CHIN DANIEL |e verfasserin |4 aut | |
245 | 1 | 0 | |a COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HEPATITIS B VIRUS |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-03-07, Last update posted on www.tib.eu: 2024-01-01, Last updated: 2024-01-05 | ||
520 | |a The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Hepatitis B Virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Hepatitis B Virus infection using said pharmaceutical composition: and methods for inhibiting the expression of a Hepatitis B Virus gene in a cell. | ||
650 | 4 | |a bio | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a C07H: Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d;aldonic acids, saccharic acids c07c0059105000, c07c0059285000;cyanohydrins c07c0255160000;glycals c07d;compounds of unknown constitution c07g;polysaccharides, derivatives thereof c08b;dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000;sugar industry c13) | |
650 | 4 | |a 615 | |
700 | 0 | |a DECKERT JOCHEN |4 aut | |
700 | 0 | |a HOSSBACH MARKUS |4 aut | |
700 | 0 | |a JOHN MATTHIAS |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 07. März |
773 | 1 | 8 | |g year:2023 |g day:07 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/47391267/publication/CA3064103A1?q=CA3064103 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 07 |c 03 |
951 | |a AR | ||
952 | |j 2023 |b 07 |c 03 |